secwatch.observer — SEC 8-K summary
======================================

Issuer:     AETHLON MEDICAL INC (AEMD)
CIK:        0000882291
Form:       8-K
Filed at:   2026-08-31T13:15:13+00:00
Accession:  0001683168-26-006815
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Aethlon Medical: all pre-funded warrants exercised; 1,604,095 shares outstanding
--------------------------------------------------------------------------------

- As of Aug 28, 2026, Aethlon Medical has 1,604,095 common shares outstanding.
- All previously outstanding pre-funded warrants have been exercised.
- CEO and CFO James B. Frakes signed the 8-K on Aug 31, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882291/000168316826006815/0001683168-26-006815-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882291/000168316826006815/aethlon_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-006815

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer